Lv7
4230 积分 2023-10-05 加入
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells
3天前
已完结
Design, Synthesis, and Biological Evaluation for First GPX4 and CDK Dual Inhibitors
3天前
已完结
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
3天前
已完结
Computer-Aided Drug Discovery for Undruggable Targets
14天前
已完结
Discovery of a Highly Potent, N-terminal Domain-targeting degrader of AR-FL/AR-V7 for the treatment of Prostate Cancer
21天前
已完结
In Vitro ADME Profiling of PROTACs: Successes, Challenges, and Lessons Learned from Analysis of Clinical PROTACs from a Diverse Physicochemical Space
1个月前
已完结
Unique targeting of androgen‐dependent and ‐independent AR signaling in prostate cancer to overcome androgen resistance
1个月前
已完结
Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments
1个月前
已完结
Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies
2个月前
已完结
皖公网安备34019202002308
